2016
DOI: 10.1038/srep24359
|View full text |Cite
|
Sign up to set email alerts
|

Engineering formation of multiple recombinant Eut protein nanocompartments in E. coli

Abstract: Compartmentalization of designed metabolic pathways within protein based nanocompartments has the potential to increase reaction efficiency in multi-step biosynthetic reactions. We previously demonstrated proof-of-concept of this aim by targeting a functional enzyme to single cellular protein nanocompartments, which were formed upon recombinant expression of the Salmonella enterica LT2 ethanolamine utilization bacterial microcompartment shell proteins EutS or EutSMNLK in Escherichia coli. To optimize this syst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
38
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(42 citation statements)
references
References 82 publications
(156 reference statements)
3
38
1
Order By: Relevance
“…Spatial organization of enzymes by encapsulation within protein shells (as exemplified in MCP systems) has the ability to accelerate catalysis, prevent side reactions, and minimize the harmful effects of toxic intermediates. A key advance in this field has been the production of empty MCP shells which were then filled with heterologous cargo by fusing targeting/ encapsulation sequences to desired enzymes/proteins (33,36,(60)(61)(62)(64)(65)(66)(67)(68). Further development of this approach for efficient encapsulation of multiple enzymes with defined stoichiometries will likely require the use of various types of targeting sequences, as well as parameterization of the molecular interactions that define encapsulation.…”
Section: Discussionmentioning
confidence: 99%
“…Spatial organization of enzymes by encapsulation within protein shells (as exemplified in MCP systems) has the ability to accelerate catalysis, prevent side reactions, and minimize the harmful effects of toxic intermediates. A key advance in this field has been the production of empty MCP shells which were then filled with heterologous cargo by fusing targeting/ encapsulation sequences to desired enzymes/proteins (33,36,(60)(61)(62)(64)(65)(66)(67)(68). Further development of this approach for efficient encapsulation of multiple enzymes with defined stoichiometries will likely require the use of various types of targeting sequences, as well as parameterization of the molecular interactions that define encapsulation.…”
Section: Discussionmentioning
confidence: 99%
“…The archetype of a prokaryotic cell lacks lipid-membrane enclosed subcellular organelles with few exceptions like magnetosomes or annamoxosomes [1,2]. Proteinaceous organelles lacking lipids, however, are widespread in prokaryotes where they often serve metabolic functions (metabolosomes) [2][3][4][5][6][7]. The prototype of this kind of subcellular biocatalytic entities is the carboxysome of cyanobacteria.…”
Section: Introductionmentioning
confidence: 99%
“…(23)(24)(25)(26), as well as to heart disease and cancer in humans due to their metabolic roles in the gut microbiome (27)(28)(29)(30). Moreover, several labs have begun to develop MCPs as a platform for protein-based containers for use in renewable chemical production, drug delivery, and the expression of toxic proteins (31)(32)(33)(34)(35)(36)(37)(38)(39)(40)(41)(42). However, as of yet, only three MCP types have been studied in any detail: the 1,2-propanediol utilization (Pdu) MCP, the ethanolamine utilization (Eut) MCP, and the carboxysome.…”
mentioning
confidence: 99%